In summary, the importance of mTOR signaling circuitry in HNSCC has been well documented, and targeting mTOR as a precision therapy approach in HNSCC has been widely investigated in experimental models, and recently tested in clinical trials. Here, MTOR is linked to head and neck squamous cell carcinoma.